| Accession Number | 0001193125-26-039795 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 3, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP and Chief Clinical Officer | Common Stock | โ | Feb 3, 2026 | Sale | 1,500 | $498.09 | $747,135.15 | 30,003 | Direct | โ | View Details | |
EVP and Chief Clinical Officer | Common Stock | โ | Feb 3, 2026 | Gift | 4,050 | $0.00 | $0.00 | 25,953 | Direct | โ | View Details |